Yahoo
OTC Markets OTCPK - Delayed Quote USD

Raia Drogasil S.A. (RADLY)

2.7600 -0.0900 (-3.16%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for RADLY
  • Previous Close 2.8500
  • Open 2.8000
  • Bid 2.7400 x 730800
  • Ask 2.8500 x 350000
  • Day's Range 2.7400 - 2.8000
  • 52 Week Range 2.7400 - 5.3420
  • Volume 643
  • Avg. Volume 144,842
  • Market Cap (intraday) 4.826B
  • Beta (5Y Monthly) 0.00
  • PE Ratio (TTM) 18.40
  • EPS (TTM) 0.1500
  • Earnings Date --
  • Forward Dividend & Yield 0.09 (3.16%)
  • 1y Target Est 5.20
  • Zacks Rating Neutral

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

rdsaude.com.br

75,594

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .

YTD Return

RADLY
35.34%
IBOVESPA (^BVSP)
4.22%

1-Year Return

RADLY
23.48%
IBOVESPA (^BVSP)
12.87%

3-Year Return

RADLY
40.84%
IBOVESPA (^BVSP)
49.22%

5-Year Return

RADLY
27.42%
IBOVESPA (^BVSP)
62.24%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 11.06B
Earnings 348.43M
Profit Margin 3.15%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
2B
4B
6B
8B
10B
12B
2.0%
2.5%
3.0%
3.5%
4.0%

Analyst Insights

View More

Analyst Price Targets

5.20
5.20 Average
2.7600 Current
5.20 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.89%

  • Return on Assets (ttm)

    7.80%

  • Return on Equity (ttm)

    19.99%

  • Revenue (ttm)

    46.53B

  • Net Income Avi to Common (ttm)

    1.4B

  • Diluted EPS (ttm)

    0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    652.95M

  • Total Debt/Equity (mrq)

    117.86%

  • Levered Free Cash Flow (ttm)

    2.18B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: